Announcement on the Establishment of intellim Thailand

This is to inform you that intellim Holdings Corporation (President & CEO: Masakuni Ukita / Tokyo Head Office: Taito-ku, Tokyo) established our 5^th overseas office, “intellim Thailand”, in Bangkok, Thailand, on October 1^st, 2019.

1.Background and Aims

intellim Group has been operating since its foundation in 2005 with the vision of “Becoming a global drug development partner representing Asia”. Following Korea, Taiwan, Malaysia, and China, we will further promote the development of pharmaceuticals by strengthening the implementation of clinical study systems in Thailand.

2.About the new company, intellim Thailand

Company Name	：	intellim Thailand Corporation
Address	：	30th Floor, Chartered Square Building, 152 North Sathorn Road Silom, Bangrak, Bangkok, 10500, Thailand
President & CEO	：	Masakuni Ukita

3.Business Description

■Drug and Medical Device Development Support in Thailand

1. Establishment of Clinical Study System in Thailand for Global Studies from Japan
2. Regulatory Consultation for New Drug Application in Thailand and Sales Support
3. Provision of Essential Education for Clinical Development